Showing results (111-120 of 125) with videos related to
Sort By:
Pageof 13
Neuron|February 14, 2007
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant gliomaKeith L Ligon, Emmanuelle Huillard, Shwetal Mehta, et al.Pigment Cell & Melanoma Research|February 18, 2018
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanomaJanice M Mehnert, Ann W Silk, J H Lee, et al.Molecular Cancer Therapeutics|June 18, 2011
Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approachJanice M Mehnert, Antoinette R Tan, Rebecca Moss, et al.JAMA Surgery|June 1, 2022
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver MetastasesDimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, et al.Nature|May 20, 2022
Compatibility rules of human enhancer and promoter sequencesDrew T Bergman, Thouis R Jones, Vincent Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignanciesEric H Rubin, Dinesh P de Alwis, Isabelle Pouliquen, et al.Communications Medicine|November 9, 2022
National and subnational short-term forecasting of COVID-19 in Germany and Poland during early 2021Johannes Bracher, Daniel Wolffram, Jannik Deuschel, et al.Cancer Gene Therapy|June 22, 2019
Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinomaDaniella E Portal, Robert E Weiss, Malgorzata Wojtowicz, et al.Environmental Science & Technology Letters|July 14, 2025
Responding after Hurricane Helene: Rapidly Estimating Impacts to Environmental Health Services in North CarolinaKelsey J Pieper, Edward Beighley, C Nathan Jones, et al.Nature Genetics|December 1, 2019
Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbationsCharles P Fulco, Joseph Nasser, Thouis R Jones, et al.Pageof 13